Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis.
Saved in:
| Title: | Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis. |
|---|---|
| Authors: | Gelmon KA; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada. Electronic address: kgelmon@bccancer.bc.ca., Fasching PA; Erlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Balmaña J; Department of Medical Oncology, Hospital Universitari Vall d'Hebron and Vall d'Hebron Institute of Oncology, Passeig de la Vall d'Hebron, Barcelona, Spain., Delaloge S; Breast Cancer Unit, Department of Cancer Medicine, Gustave Roussy, Villejuif, France., Labidi-Galy I; Department of Oncology, Hôpitaux Universitaires de Genève, Geneva, Switzerland., Bennett J; AstraZeneca, Cambridge, UK., McCutcheon S; AstraZeneca, Cambridge, UK., Walker G; AstraZeneca, Cambridge, UK., O'Shaughnessy J; Baylor University Medical Centre, Texas Oncology and US Oncology, Dallas, TX, USA. |
| Corporate Authors: | Collaborating Investigators |
| Source: | European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Jul; Vol. 152, pp. 68-77. Date of Electronic Publication: 2021 Jun 01. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1879-0852 |
|---|---|
| DOI: | 10.1016/j.ejca.2021.03.029 |
